Our NAV-005 antagonist binds the immunosuppressive HIO-1 factor and blocks its ability to suppress mAb, TCE and ADC ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...

Due to the “programmable” nature of the nanoparticle, researchers are able to “swap out the antibodies or the drugs to target different diseases — like autoimmune disorders or different types of ...

In the treatment of inflammatory bowel disease, synthetic mucus gels can be used to deliver monoclonal antibodies without inducing broad immunosuppression.

By extending a naturally rigid bacterial protein by 50% while preserving geometry and stability, the study introduces protein ...

GSK is staking billions on a new way to protect people from life‑threatening food allergies, agreeing to buy RAPT ...

Researchers have harnessed AI to expedite the creation of lightbulb-like intrabody probes that can track activity in living ...

Precise methods for shredding or repairing and replacing specific cancer-causing proteins in a malignant cell, developed at ...

Artificial intelligence (AI) and “protein language” models can speed the design of monoclonal antibodies that prevent or reduce the severity of potentially life-threatening viral infections, according ...

Learn how pH-sensitive dye detection supports reliable ADC internalization assays and insight into cellular uptake mechanisms ...

ADC conjugation, redefined. Explore a rapid 3-hour workflow that delivers precise, controlled antibody-drug conjugates for ...

A research team engineered a rigid, nanometer-scale protein module to address the challenge of measuring antibody flexibility ...